Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges - WSJ
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Why Teva Paid $40.5 Billion for Allergan's Generic Business - Knowledge at Wharton
Teva Pharmaceutical Industries Ltd. - As well as sticking to treatment, taking care of yourself and staying healthy are the best ways to help keep #asthma symptoms under control. #WorldAsthmaDay https://bit.ly/2StbL77
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
Teva Pharmaceuticals expands strategic partnership with Alvotech
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Pharmaceutical Industries Ltd. Company Profile - Market.us
Drug companies fixed prices over martinis at 'Girls Nights Out,' lawsuit says | PBS NewsHour
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva gets a boost as billionaire Buffett reports $358M stake | Fierce Pharma
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Teva Pharmaceuticals - Wikipedia
Health-care, biotech stocks slammed by Trump remarks
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva rolls along in 2nd year of 'Pivot to Growth' strategy
